Cybin faces clinical trial delays, leadership changes, and cash burn concerns. Learn why CYBN's outlook has been downgraded ...

The Annual Outsourcing in Clinical Trials & Clinical Trial Supply Nordics 2025 conference will gather experts to discuss ...

Ginger is known for its soothing effects on the stomach, and can effectively relieve nausea. It may also play a role in reducing migraine symptoms.

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

Medpace Hldgs (NASDAQ: MEDP) will release its quarterly earnings report on Wednesday, 2025-10-22. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Medpace Hldgs to ...

The latest announcement is out from Xuanzhu Biopharmaceutical Co., Ltd. Class H ( ($HK:2575) ). Xuanzhu Biopharmaceutical Co., Ltd. announced ...

Panelists discuss how maintaining patients on effective single therapies for Crohn’s disease is preferable to switching ...

The medical device industry has a jam-packed year of events for professionals to attend, including the J.P. Morgan Healthcare ...

In the Phase 2 TEASE 2 trial, gildeuretinol was well tolerated and showed promising trends in slowing ellipsoid zone loss and preserving low-luminance visual acuity in patients with Stargardt disease.

Rubrik has been named a Leader in the IDC MarketScape for cyber recovery. Rubrik was recognized for strengths in extensive threat detection capabilities, DSPM and identity resilience, ransomware ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...